FIELD: medicine.
SUBSTANCE: method involves applying xanthanic pitch as active base in pharmaceutical composition possessing reepithelialization properties and optionally but not obligatory mixed with hyaluronic acid.
EFFECT: accelerated and improved process of new epithelium growth.
21 cl, 11 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| OPHTHALMIC COMPOSITIONS OF TAMARIND SEED POLYSACCHARIDE AND HYALURONIC ACID | 2008 |
|
RU2493855C2 |
| USE OF PLANT EXTRACT AS ACTIVE AGENT IN PROCESSES OF REEPITHELIZATION AND CICATRIZATION OF TISSUE | 2018 |
|
RU2782198C2 |
| AGENTS FOR APPLICATION INTO EYE CORNEA OR STROMA FOR TREATMENT OF PREVENTION OF OPHTHALMOLOGICAL DISORDERS | 2003 |
|
RU2363459C2 |
| OPHTHALMOLOGICAL COMPOSITION, BASED ON POLYUNSATURATED FATTY ACIDS OMEGA-3 AND OMEGA-6 | 2010 |
|
RU2545675C2 |
| OPHTHALMIC COMPOSITIONS CONTAINING MUCOADHESIVE POLYSACCHARIDES ABLE TO PROMOTE CORNEAL RE-EPITHELISATION | 2013 |
|
RU2663449C2 |
| OPHTHALMIC COMPOSITIONS CONTAINING MUCOADHESIVE POLYSACCHARIDES STIMULATING CORNEAL EPITHELIUM RECOVERY | 2006 |
|
RU2493854C2 |
| PHARMACEUTICAL FORMULATIONS OF NON-POLAR AND POLAR LIPIDS FOR OPHTHALMOLOGICAL APPLICATION | 2007 |
|
RU2495661C2 |
| EYE DROPS BASED ON COMPOSITION OF PHARMACEUTICALLY ACCEPTABLE ADDITIVE ACID SALTS AND METHYLETHYL PYRIDONOL AND TAURINE CONTAINING COMPOSITION OF GROUP B VITAMINS | 2013 |
|
RU2533276C1 |
| EXTRACELLULAR HYALURONIDASE FROM Streptomyces koganeiensis | 2010 |
|
RU2553205C2 |
| PYRROLIDONE-CARBOXYLIC ACID (PCA) FOR OPHTHALMIC USE | 2016 |
|
RU2720993C2 |
